Urinalysis Test Market is Projected to reach USD 698.85 million by 2023 & CAGR Of 6.3%

Market Research Future has a cooked research report on the World urinalysis test market. The global urinalysis test Industry is growing continuously and is expected to grow at a CAGR of 6.3% from 2017 to 2023.

The demand for urinalysis test is increasing with increasing prevalence of chronic diseases and demand for new point of care devices. The global market is expected to grow at a CAGR of 6.3% during the forecast period.
Urinalysis is the analysis of urine for the diagnosis and monitoring of number of diseases such as kidney disease and diabetes. The test is mostly recommended during pregnancy to determine the levels of hormone called “human chorionic gonadotropin”. Therefore, the demand for these test instruments and devices is growing across the globe.
Taste the market data and market information presented through more than 120 market data tables and figures spread over 158 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Urinalysis test market research report–Global forecast till 2023.”

Sample Report Available at https://www.marketresearchfuture.com/sample_request/839 .

Major Players in the Market:
World market are Dahaner (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Siemens AG (U.S.), ARKRAY, Inc. (Japan), Sysmex Corporation (Japan), and ACON Laboratories, Inc. (U.S.).

Key Findings:
• Consumables segment accounted for the largest market share in 2016
• The global urinalysis test market by test type is expected to reach USD 698.85 million by 2023
• Sediments/microscopic urinalysis is the fastest growing segment, which is projected to grow at a CAGR of 7.13% % during the forecast period of 2017-2023
• Pregnancy tests segment accounted for the largest market share in 2016
• American region captures the major market share and is expected to reach USD 594.21 million by 2023
The global urinalysis test market is segmented on the basis of type of product type, test type, application and end user.
On the basis of product type, the market is segmented into instruments and consumables. The instruments include urine chemistry analyzer such as automatic urine analyzers and semi-automatic urine analyzers, automated urine sediment analyzers, point-of-care devices, and strip analyzer. The consumables are further segmented into plastic consumables, test strips, and chemical agents.
On the basis of test type, the market is segmented into macroscopic urinalysis, biochemical urinalysis, and sediments/microscopic urinalysis.
On the basis of application, the market is segmented into disease diagnosis including the diagnosis of diseases such as kidney disease, liver disease, diabetes, pregnancy tests, and others.
On the basis of end user, the market is segmented into hospitals, independent laboratories, and physician practices.

Browse complete report at https://www.marketresearchfuture.com/reports/urinalysis-test-market-839 .

Regional Analysis
The Americas is the largest urinalysis tests market across the globe owing to extensive use and demand for automated point-of-care testing devices, and rising prevalence of chronic kidney diseases (CKD). According to the National Chronic Kidney Diseases Report, CKD is common among adults in the U.S.
Europe is the second largest market and it is expected to show positive growth in the near future due to the increasing prevalence of Chronic Kidney Disease (CKD) and diabetes. As per American Society of Nephrology, the prevalence of CKD across the European countries is varied. According to the World Health Organization, about 60 million European have diabetes and the prevalence of diabetes is relatively high among people over 25 years.
In Asia Pacific, the market is expected grow at the fastest rate owing to increasing prevalence of chronic disease such as diabetes, kidney diseases, and others. Furthermore, the demand for diagnostics services in this region is increasing with the increasing medical tourism. India is one of the international medical tourism destinations across the world, which further exhibits growth opportunities for the market due to availability of cost-effective treatment and rising success rates. Furthermore, the increasing healthcare expenditure in the developing countries of Asia Pacific also contributes to the market growth.
The Middle East and Africa also shows a steady rise in the market owing to rising demand for agnostic solutions and point-of-care testing devices.

Ask question to expert at https://www.marketresearchfuture.com/enquiry/839 .

List of Tables

TABLE 1 PRIMARY INTERVIEWS 20
TABLE 2 GLOBAL URINALYSIS TEST MARKET, BY PRODUCT TYPE, 2014-2023 (USD MILLION) 40
TABLE 3 GLOBAL INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 41
TABLE 4 GLOBAL CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 41
TABLE 5 GLOBAL URINALYSIS TEST MARKET FOR INSTRUMENTS, BY REGION, 2014-2023 (USD MILLION) 43
TABLE 6 GLOBAL URINALYSIS TEST MARKET FOR CONSUMABLES, BY REGION, 2014-2023 (USD MILLION) 45
TABLE 7 GLOBAL URINALYSIS TEST MARKET, BY TEST TYPE, 2014-2023 (USD MILLION) 46
TABLE 8 GLOBAL URINALYSIS TEST MARKET FOR MACROSCOPIC URINALYSIS, BY REGION, 2014-2023 (USD MILLION) 47
TABLE 9 GLOBAL URINALYSIS TEST MARKET FOR BIOCHEMICAL URINALYSIS, BY REGION, 2014-2023 (USD MILLION) 48
TABLE 10 GLOBAL URINALYSIS TEST MARKET FOR SEDIMENTS/MICROSCOPIC URINALYSIS, BY REGION, 2014-2023 (USD MILLION) 49
Continue…

Contact:
Market Research Future
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@Marketresearchfuture.Com

About us
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@Marketresearchfuture.Com

This release was published on openPR.